Cargando…
A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom
Extracorporeal photopheresis (ECP) is a second‐line therapy in acute and chronic GVHD and solid organ transplant rejection. We report ECP use in 98 pediatric patients in seven UK centers from 2010 to 2017, the majority treated for aGVHD (73.5%). ECP was safe and well tolerated including in low body...
Autores principales: | Flinn, Aisling M., Macheka, Sheba, Slatter, Mary, Ewins, Anna‐Maria, Gibson, Brenda, Lawson, Sarah, Tailby, Anna, Lucchini, Giovanna, New, Helen, James, Beki, Alfred, Arun, Scarisbrick, Julia, Gennery, Andrew R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175897/ https://www.ncbi.nlm.nih.gov/pubmed/35847736 http://dx.doi.org/10.1002/jha2.58 |
Ejemplares similares
-
Thymopoiesis, Alterations in Dendritic Cells and Tregs, and Reduced T Cell Activation in Successful Extracorporeal Photopheresis Treatment of GVHD
por: Flinn, Aisling M., et al.
Publicado: (2021) -
Extracoporeal photopheresis treatment of acute graft-versus-host disease following allogeneic haematopoietic stem cell transplantation
por: Flinn, Aisling M., et al.
Publicado: (2016) -
P1578: SERUM EXTRACELLULAR VESICLE MIRNA PROFILING TO DETERMINE EXTRACORPOREAL PHOTOPHERESIS TREATMENT RESPONSE IN GRAFT VERSUS HOST DISEASE PATIENTS
por: Schell, Kimberly, et al.
Publicado: (2023) -
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
por: Alfred, Arun, et al.
Publicado: (2017) -
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
por: Bojanic, Ines, et al.
Publicado: (2023)